Corrigendum to "Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer" [Biomaterials 46 (2015) 13-25]

The authors regret that in Page-22, Fig. 7E: There were inadvertent duplications of images in the LENP-Gem and ENP-Gem-si-HIF1α groups of Fig. 7E. The corrected images, obtained from original data, should appear as shown below. These changes do not affect the interpretation of data or the conclusion of the study. [Figure presented] The authors would like to apologise for any inconvenience caused.